Multi-Cancer Early Detection: New Tests Under Medicare
This act aims to expand Medicare coverage to include new screening tests that allow for the early detection of multiple types of cancer simultaneously. This means Medicare beneficiaries will gain access to innovative screenings, potentially improving treatment effectiveness and reducing costs. Early cancer detection often leads to less invasive treatments and higher survival rates.
Key points
Medicare will cover new multi-cancer early detection screening tests, including blood-based and other biological material tests.
These tests will be available to Medicare beneficiaries once every 11 months, after approval by the Food and Drug Administration (FDA).
The new tests will complement, not replace, existing cancer screenings (e.g., mammograms, colonoscopies), increasing the chances of early cancer detection.
Early cancer detection can lead to less invasive and less expensive treatments, and help reduce health disparities.
Expired
Citizen Poll